Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Handelsbanken Nordic Mid/Small Cap Seminar
Camurus' Chief Business Development Officer, Fredrik Joabsson, will give a company presentation at 11am 9 June, which can be seen by the conference participants.
BIO International Convention 2022
Camurus will participate in this conference in San Diego, CA, US, 13-16 June, 2022.
Interim Report January-June 2022
The interim report January-June is published on 15 July 2022.
Annual General Meeting
The Annual General Meeting 2022 in Camurus was held Thursday, 12 May 2022 at Elite Hotel Ideon in Lund. See more information
Diversified pipeline with large potential
Camurus' innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders